Dr. Agarwal's Health Care valuation

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025
Price multiples — at each FY-end close
101.42×——
7.43×——
6.82×——
257.63×——
Enterprise multiples
6.82×——
24.60×——
46.98×——
Yield
1.0%——
0.4%——
Reference — adjusted share basis
₹475.00——
₹4.68₹4.20₹2.63
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

AGARWALEYE₹475.00

Dr. Agarwal's Health Care Ltd.

· Pharma & Health
₹ CrorePeersAKUMSADVENZYMESALIVUSAARTIPHARMAARTIDRUGSAPLLTDCORONAHCGMcap ₹15,048 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
Multiples — ₹ Crore base
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Price Multiples — at each FY-end close
P/E——101.42
P/B——7.43
P/Sales——6.82
Price to Free Cash Flow——257.63
Enterprise Multiples
EV/Sales——6.82
EV/EBITDA——24.60
EV/EBIT——46.98
Yield
Earnings Yield %——0.99
FCF Yield %——0.39
Reference — adjusted share basis
Price (FY-end close, adj.)——475.00
EPS (adj.)2.634.204.68
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.